Oncology and Translational Medicine
Oncology and Translational Medicine (OTM), a peer-reviewed open-access journal, is sponsored by Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China (English, bimonthly, CN 42-1865/R, ISSN 2095-9621). OTM mainly publishes original and review articles on oncology and translational medicine. We are working with the commitment to bring the highest quality research to the widest possible audience and share the research work in a timely fashion. Manuscripts considered for publication include regular scientific papers, original research, brief reports and case reports. Review articles, commentaries and letters are welcome.
Aims & Scope
Oncology and Translational Medicine is an international professional academic periodical. The Journal is designed to report progress in research and the latest findings in domestic and international oncology and translational medicine, to facilitate international academic exchanges, and to promote research in oncology and translational medicine as well as levels of service in clinical practice. The entire journal is published in English for a domestic and international readership.
Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out. The author warrants that his/her contribution is original and that he/she has full power to make this grant. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Huazhong University of Science and Technology becomes effective if and when the article is accepted for publication. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Huazhong University of Science and Technology. The copyright covers the exclusive right and license (for U.S. government employees: to the extent transferable) to reproduce, publish, distribute and archive the article in all forms and media of expression now known or developed in the future, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature.Supervised by
Ministry of Education of the People’s Republic of China.
Tongji Medical College, Huazhong University of Science and Technology.
Manuscripts should be submitted to:
ISSN edition: 2095-9621
■ Subscription rates
Subscription may begin at any time. Remittances made by check, draft or express money order should be made payable to this journal. The price for 2018 is as follows: US $ 30 per issue; RMB ￥28.00 per issue.
Oncology and Translational Medicine is abstracted and indexed in EMBASE, Index Copernicus, Chinese Science and Technology Paper Citation Database (CSTPCD), Chinese Core Journals Database, Chinese Journal Full-text Database (CJFD), Wanfang Data; Weipu Data; Chinese Academic Journal Comprehensive Evaluation Database.
All matters relating to orders, subscriptions, back issues, offprints, advertisement booking and general enquiries should be addressed to the editorial office.
Editorial office of Oncology and Translational Medicine
Tongji Medical College
Huazhong University of Science and Technology
Jie Fang Da Dao 1095
430030 Wuhan, China
Email: firstname.lastname@example.org; email@example.com
Changjiang Spatial Information Technology Engineering Co., Ltd. (Wuhan) Hangce Information Cartorgraphy Printing Filial, Wuhan, China
Printed in People’s Republic of China